Strategies for managing sexual dysfunction induced by antidepressant medication

Area of Science:

• Psychiatry
• Pharmacology
• Sexual Medicine

Background:

• Sexual dysfunction is a frequent side effect of antidepressant medications.
• These side effects can negatively impact lifestyle and treatment adherence, affecting mental health.
• Management strategies are needed to address this common issue.

Purpose of the Study:

• To review and assess the effectiveness of various management strategies for sexual dysfunction caused by antidepressant use.
• To synthesize evidence from randomized controlled trials on treatment options.

Main Methods:

• Comprehensive literature search of multiple databases (CCDANCTR, Cochrane, MEDLINE, EMBASE, CINAHL, PsycINFO) and expert consultation.
• Inclusion of randomized controlled trials comparing management strategies for antidepressant-induced sexual dysfunction.
• Independent data extraction and quality assessment by two reviewers, with author contact for additional information.

Main Results:

• Fifteen trials involving 904 participants were analyzed.
• Switching to nefazodone was effective in reducing sexual dysfunction compared to restarting sertraline.
• Adding sildenafil or tadalafil showed significant improvements for erectile dysfunction, while bupropion improved desire.
• Other augmentation strategies did not demonstrate statistically significant benefits over placebo.

Conclusions:

• Current evidence for managing antidepressant-induced sexual dysfunction is limited by small trial sizes.
• For men experiencing antidepressant-induced erectile dysfunction, adding sildenafil is a promising strategy.
• Further randomized controlled trials are needed to fully establish the efficacy of various interventions.